UNSPSC 51401906: Rilmazafone hydrochloride

This classification denotes a sedative and hypnotic with the molecular structure C21H20CL2N6O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 25T258X8BV chemically known as 5-(((2-aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-1h-1,2,4-triazole-3-carboxamide hydrochloride, but more commonly known as rilmazafone hydrochloride, which bears US NIH Compound Identifier 135366.

European Medicines Agency schedules Rilmazafone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22078. Most nations, for tariff and trade purposes, schedule rilmazafone hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, RILMAZAFONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)C(=O)C1NC(N(N1)C2CCC(CC2C(=O)C3CCCCC3CL)CL)CNC(=O)CN.CL.

UNSPSC 51401906 Rilmazafone hydrochloride is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The most recent opportunity posted under this code is Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—a public health procurement unrelated to rilmazafone hydrochloride, a benzodiazepine anxiolytic. This mismatch signals either a data-entry error in the county's tagging system or a misclassification of the opportunity at posting. The code shows no additional recent state and local opportunities that correspond to its nominal pharmaceutical scope.

Without recent opportunities actually aligned to rilmazafone hydrochloride procurement, business development professionals should treat this code as inactive for state and local contract pursuit at present. Verify the actual UNSPSC classification for naloxone and drug-deactivation products if pursuing the Seminole County opportunity, as the current tagging does not reflect genuine demand for rilmazafone in the state and local market.